| Discrete choice experiments in health economics: a review of the literature EW de Bekker‐Grob, M Ryan, K Gerard Health economics 21 (2), 145-172, 2012 | 1480 | 2012 |
| Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations D Husereau, M Drummond, F Augustovski, E de Bekker-Grob, AH Briggs, ... MDM Policy & Practice 7 (1), 23814683211061097, 2022 | 1417 | 2022 |
| Discrete choice experiments in health economics: a review of the literature MD Clark, D Determann, S Petrou, D Moro, EW de Bekker-Grob Pharmacoeconomics 32, 883-902, 2014 | 835 | 2014 |
| Sample size requirements for discrete-choice experiments in healthcare: a practical guide EW de Bekker-Grob, B Donkers, MF Jonker, EA Stolk The Patient-Patient-Centered Outcomes Research 8, 373-384, 2015 | 814 | 2015 |
| Discrete choice experiments in health economics: past, present and future V Soekhai, EW de Bekker-Grob, AR Ellis, CM Vass Pharmacoeconomics 37, 201-226, 2019 | 681 | 2019 |
| Consolidated health economic evaluation reporting standards (CHEERS) 2022 explanation and elaboration: a report of the ISPOR CHEERS II good practices task force D Husereau, M Drummond, F Augustovski, E de Bekker-Grob, AH Briggs, ... Value in health 25 (1), 10-31, 2022 | 520 | 2022 |
| Labeled versus unlabeled discrete choice experiments in health economics: an application to colorectal cancer screening EW De Bekker‐Grob, L Hol, B Donkers, L Van Dam, JDF Habbema, ... Value in Health 13 (2), 315-323, 2010 | 243 | 2010 |
| The effect of including an opt-out option in discrete choice experiments J Veldwijk, MS Lambooij, EW de Bekker-Grob, HA Smit, GA de Wit PloS one 9 (11), e111805, 2014 | 226 | 2014 |
| Factors affecting food choices of older adults from high and low socioeconomic groups: a discrete choice experiment CBM Kamphuis, EW de Bekker-Grob, FJ van Lenthe The American journal of clinical nutrition 101 (4), 768-774, 2015 | 195 | 2015 |
| CHEERS 2022 ISPOR Good Research Practices Task Force. Consolidated health economic evaluation reporting standards 2022 (CHEERS 2022) statement: updated reporting guidance for … D Husereau, M Drummond, F Augustovski, E de Bekker-Grob, AH Briggs, ... Value Health 25 (1), 3-9, 2022 | 174 | 2022 |
| Methods for exploring and eliciting patient preferences in the medical product lifecycle: a literature review V Soekhai, C Whichello, B Levitan, J Veldwijk, CA Pinto, B Donkers, ... Drug discovery today 24 (7), 1324-1331, 2019 | 155 | 2019 |
| COVID-19 contact tracing apps: predicted uptake in the Netherlands based on a discrete choice experiment M Jonker, E de Bekker-Grob, J Veldwijk, L Goossens, S Bour, ... JMIR mHealth and uHealth 8 (10), e20741, 2020 | 128 | 2020 |
| Are healthcare choices predictable? The impact of discrete choice experiment designs and models EW de Bekker-Grob, JD Swait, HT Kassahun, MCJ Bliemer, MF Jonker, ... Value in Health 22 (9), 1050-1062, 2019 | 126 | 2019 |
| Giving patients’ preferences a voice in medical treatment life cycle: the PREFER public–private project EW de Bekker-Grob, C Berlin, B Levitan, K Raza, K Christoforidi, ... The Patient-Patient-Centered Outcomes Research 10, 263-266, 2017 | 119 | 2017 |
| Acceptance of vaccinations in pandemic outbreaks: a discrete choice experiment D Determann, IJ Korfage, MS Lambooij, M Bliemer, JH Richardus, ... PloS one 9 (7), e102505, 2014 | 116 | 2014 |
| The added value of percentage of free to total prostate-specific antigen, PCA3, and a kallikrein panel to the ERSPC risk calculator for prostate cancer in prescreened men MM Vedder, EW de Bekker-Grob, HG Lilja, AJ Vickers, ... European urology 66 (6), 1109-1115, 2014 | 108 | 2014 |
| Surveillance in patients with long-segment Barrett's oesophagus: a cost-effectiveness analysis F Kastelein, S van Olphen, EW Steyerberg, M Sikkema, MCW Spaander, ... Gut 64 (6), 864-871, 2015 | 99 | 2015 |
| Can healthcare choice be predicted using stated preference data? EW de Bekker-Grob, B Donkers, MCJ Bliemer, J Veldwijk, JD Swait Social Science & Medicine 246, 112736, 2020 | 98 | 2020 |
| Preferences for colorectal cancer screening strategies: a discrete choice experiment L Hol, EW de Bekker-Grob, L van Dam, B Donkers, EJ Kuipers, ... British journal of cancer 102 (6), 972-980, 2010 | 98 | 2010 |
| Factors and situations influencing the value of patient preference studies along the medical product lifecycle: a literature review E van Overbeeke, C Whichello, R Janssens, J Veldwijk, I Cleemput, ... Drug discovery today 24 (1), 57-68, 2019 | 97 | 2019 |
